Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (DE:3F8)
FRANKFURT:3F8
Holding DE:3F8?
Track your performance easily
3F8 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.05 - €0.36
Previous Close€0.05
Volume0.00
Average Volume (3M)N/A
Market Cap
€11.09M
Enterprise Value€4.82M
Total Cash (Recent Filing)kr72.62M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)11.37
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Q-linea AB News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
3F8 FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was €0.05 and its highest was €0.36 in the past 12 months.
What is Q-linea AB’s market cap?
Currently, no data Available
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Feb 13, 2025 which is in 82 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Nov 05, 2024. The company reported -€0.031 earnings per share for the quarter, beating the consensus estimate of -€0.035 by €0.003.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 117,166,374 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -€0.031 in its last earnings report, beating expectations of -€0.035. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in DE:3F8
---
Q-linea AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.41%
12-Months-Change
Fundamentals
Return on Equity
-162.66%
Trailing 12-Months
Asset Growth
-50.60%
Trailing 12-Months
Company Description
Q-linea AB
Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
---
Technical Analysis
---